Mettler-Toledo International (MTD)☆

Mettler-Toledo makes precision instruments and laboratory balances. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

Mettler-Toledo International trades on the NYSE under the ticker symbol MTD. As of the most recent market data, the stock was priced around $1,405.14, up 0.47% on the session, giving Mettler-Toledo International a market capitalization of roughly $28.15B.

Over the past 52 weeks, MTD has traded between $1,023.05 and $1,525.17. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 31.5, a common gauge of how richly the market prices the company's earnings.

As one of the larger companies in the Health Care sector, Mettler-Toledo International is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch MTD for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.